[99mTc]Tc-DB8 Accumulation in Primary Tumor in Breast Cancer With Positive and Negative Estrogen Receptor Expression

NCT07275463 · clinicaltrials.gov ↗

PHASE2

Phase

ENROLLING_BY_INVITATION

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Primary Breast Cancer

Interventions

DRUG: [99mTc]Tc-DB8

Sponsor

Tomsk National Research Medical Center of the Russian Academy of Sciences

Collaborators

[object Object]